Certolizumab pegol in a heterogeneous population of patients with moderate-to-severe rheumatoid arthritis

Enrique R Soriano, Analia Dellepiane, Gabriela Salvatierra, Cristian Alejandro Benítez, Rodrigo Garcia Salinas, Carlos Baruzzo
  • Future Science OA, February 2018, Future Science
  • DOI: 10.4155/fsoa-2017-0149
The author haven't yet claimed this publicationThe author haven't yet claimed this publication
Read Publication

http://dx.doi.org/10.4155/fsoa-2017-0149

In partnership with: